Best medical therapy or wishful thinking in carotid disease? A single-centre audit in Germany

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 4, 2011, Pages 501-506

  Lutz, H J ^a   Sacuiu, R D ^a   Gahl, B ^b   Savolainen, H ^c  

^a Verbundkrankenhaus Bernkastel/Wittlich ^*  (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c QUEEN ELIZABETH HOSPITAL   (Barbados)

Author keywords

Best medical treatment; Carotid disease; Carotid stenosis; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HEMOGLOBIN A1C; HEPPERFUSOR; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BODY MASS; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; DEATH; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; GERMANY; HEMOGLOBIN DETERMINATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASYMPTOMATIC DISEASES; CARDIOVASCULAR AGENTS; CAROTID ARTERY DISEASES; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CLINICAL AUDIT; ENDARTERECTOMY, CAROTID; EVIDENCE-BASED MEDICINE; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; GUIDELINE ADHERENCE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 79953053813     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.12.006     Document Type: Article

References (39)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
2. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-87.
3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (ACAS). Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
4. Halliday A, Mansfield A, Marro J, MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-502.
5. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, et al. Guidelines for carotid endarterectomy. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1998;97:501e9.
6. Stroke 1998;29:554-562.
7. Halliday A, Harrison M, Hayter E, Xiangling K, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicenter randomised trial. Lancet 2010;376:1074-84.
8. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40(10):e573- 83.
9. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatc carotid stenosis on best medical treatment. A prospective, population e based study. Stroke 2010;41:e11-7.
10. Sillesen H. What does "best medical therapy" really mean? Eur J Vasc Endovasc Surg 2008;35:139-44.
11. Mills EJ, Wu P, Chong G, Ghement I, Sing S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta e analysis of 170255 patients from 76 randomised trials. QJM 2010. Oct 7 (Epub ahead of print).
12. Kulkens S, Ringleb PA, Hacke W. Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic strokeeupdate 2003. Part 2: prevention and rehabilitation. Nervenarzt 2004;75(4):380-8.
13. Poulter N. Coronary heart disease is a multifactorial disease. Am J Hypertens 1999;22:92s-5s.
14. Olsen TS, Langhorne P, Diener HC, Hennerici M, Ferro J, Sivenius J, et al. European Stroke Initiative Recommendations for stroke management e update 2003. Cerebrovasc Dis 2003;16(4):311-37.
15. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systemic review and up-to-date meta-analysis. Stroke 2004;35(12):2902-9. (Pubitemid 39565192)
16. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-86.
17. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirine in patients at risk of ischemic events (CAPRIE). Lancet 1996;348:1329-39.
18. Bhatt DL, Topol EJ. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J (United States) 2004;148(2):263-8.
19. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143(1e2):1-13. (Pubitemid 26402780)
20. Hall JE. Control of blood pressure by the renin-angiotensin-aldosteron system. Clin Cardiol 1991 Aug;14(8 Suppl. 4):IV6-21.
21. Mancini GB. Role of angiotensineconverting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am J Med 1998;105(1A):40S-7S.
22. Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Clin Ther 2009;11:2628-52.
23. Austin PC, Tu JV, Ko DT, Alter SA. Factors associatedwith the use of evidenceebasedtherapies after dischargeamong elderly patients with myocardial infarctions. CMAJ 2008;179(9):901-8.
24. Henriksson M, Lundgren F, Carlsson P. Cost e effectiveness of carotid endarterectomy in patients with asymptomatic carotid artery stenosis. Br J Surg 2008;95(6):714-20.
25. Duckworth W, Abraira C, Moritz T. VA Diabetes Trial. Glucose control and vascular complications in veterans with type 2 diabetes. NEJM 2009;360:129-39.
26. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al., (ADVANCE Collaborative Group). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358(24):2560-72. (Pubitemid 351831357)
27. McGee DL. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005;15(2):87-97. (Pubitemid 40126638)
28. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleemann JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International association for the Study of Obesity. Circulation 2009;120:1640-5.
29. Mahe G, Ronziere T, Laviolle B, Golfier V, Cochery T, Bray JM, et al. An unfavourable dietary pattern is associated with symptomatic ischemic stroke and carotid atherosclerosis. J Vasc Surg 2010;52:62-8.
30. Matteson ML, Russel C. Interventions to improve hemodialysis adherence: a systematic review of randomized-controlled trials. Hemodial Int 2010. Aug 2010 (Epub ahead of print).
31. Hershmann DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2010. Aug 28 (Epub ahead of print).
32. Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, et al. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. Arch Cardiovasc Dis 2010;6-7:363-75.
33. Tarantino V, Cappellari G, Cardaioli C, Rumiati R, Savadori L, Barilli, et al. Sociocognitive factors associated with nonadherence to medication after hospital discharge. Behav Med 2010;3:100-7.
34. Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult eto e control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non e responsiveness from non e adherence to recommended therapy. Hypertens Res 2010. Sep 30 (Epub ahead of print).
35. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in primary and secondary prevention of vascular disease: collaborative meta e analysis of individual participant data from randomised trials. Lancet 2009;373(9678):1849-60.
36. Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, et al. Population based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention. Circulation 2008;118:428-64.
37. www.space-2.de.
38. Transatlantic debate Schneider PA, Naylor AR. Asymptomatic carotid artery stenosis e medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. Eur J Vasc Surg 2010;40:274-81.
39. Roffi M, Spence JD. Is there a role for revascularisation in asymptomatic carotid stenosis ? BMJ 2010;341:c4900.